Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||Anti-SLAMF7 CAR T cells|
Anti-SLAMF7 CAR T cells are T-cells that express a chimeric antigen receptor derived from the SLAMF7 (CS1)-targeting antibody elotuzumab, which potentially results in anti-tumor activity against SLAMF7-expressing tumor cells (PMID: 29089311).
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Anti-SLAMF7 CAR T cells||Anti-SLAMF7 CAR T cells||0||0|
|Anti-SLAMF7 CAR T cells + Cyclophosphamide + Fludarabine||Anti-SLAMF7 CAR T cells Cyclophosphamide Fludarabine||0||1|